Disc Medicine (IRON) Cash & Equivalents (2020 - 2026)

Disc Medicine (IRON) has 7 years of Cash & Equivalents data on file, last reported at $88.9 million in Q1 2026.

• On a quarterly basis, Cash & Equivalents fell 27.52% year-over-year to $88.9 million in Q1 2026; TTM through Mar 2026 was $88.9 million, a 27.52% decrease from a year earlier, with the FY2025 full-year figure at $91.1 million, down 52.64% from the prior year.
• Cash & Equivalents for Q1 2026 stood at $88.9 million, down from $91.1 million in the prior quarter.
• Over the last five years, Cash & Equivalents for IRON reached as high as $377.6 million in Q2 2023 and fell as low as $88.9 million in Q1 2026.
• Historically, Cash & Equivalents has averaged $202.8 million across 5 years, with a median of $192.4 million in 2024.
• Across the five-year window, Cash & Equivalents jumped 264.17% in 2023 and slumped 64.19% in 2025, its largest moves.
• Year by year, Cash & Equivalents stood at $194.6 million in 2022, then soared by 85.18% to $360.4 million in 2023, then sank by 46.6% to $192.4 million in 2024, then plunged by 52.64% to $91.1 million in 2025, then declined by 2.45% to $88.9 million in 2026.
• Per Business Quant data, the three most recent Cash & Equivalents figures were $88.9 million in Q1 2026, $91.1 million in Q4 2025, and $140.7 million in Q3 2025.